megestrol has been researched along with tamoxifen in 79 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 34 (43.04) | 18.7374 |
1990's | 36 (45.57) | 18.2507 |
2000's | 7 (8.86) | 29.6817 |
2010's | 2 (2.53) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Altaras, M; Beyth, Y; Cohen, I; Cordoba, M; Rosen, D; Shapira, J | 1 |
Blamey, RW; Chan, S; Dixon, AR; Haybittle, J; Jackson, L | 1 |
Bates, K; Blamey, RW; Nicholson, RI; Pearson, D; Robertson, JF | 1 |
Larsen, M; Pors, H; Sørensen, OS; von Eyben, FE | 1 |
Stoll, BA | 1 |
Daniel, F; Rao, DG; Tyrrell, CJ | 1 |
Brenner, BG; Margolese, RG | 1 |
Blamey, RW; Griffiths, K; Pearson, D; Turkes, A; Williams, MR | 2 |
Canetta, R; Kelley, S; Nicaise, C; Rozencweig, M; Schacter, LP; Smaldone, L | 1 |
Dahrouge, S; Fine, S; Hanson, J; McDermot, RS; Paterson, AH; Pritchard, KI; Sansregret, E; Stewart, DJ; Trudeau, M; White, DF | 1 |
Fellowes, G; Larsen, W; Rickman, LS | 1 |
Hunter, RE; Longcope, C; Reale, FR; Rose, PG | 1 |
Albert, J; Berry, CC; Fay, W; Geller, J; Liu, J | 1 |
Canetta, R; Kelley, S; Nicaise, C; Rozencweig, M; Schacter, L; Smaldone, L | 1 |
Gerner, EW | 1 |
Gundersen, S; Klepp, R; Kvinnsland, S; Lund, E; Lundgren, S; Lønning, PE | 1 |
Blamey, RW; Morgan, DA; Nicholson, RI; Robertson, JF; Todd, J; Williams, MR | 1 |
Kvinnsland, S; Lönning, PE; Lundgren, S; Wiedemann, G | 1 |
Glick, JH; Haller, DG | 1 |
Allegra, J; Bertino, JR; Bonomi, P; Browder, H; Byrne, P; Carpenter, J; Catalano, R; Creech, R; Dana, B; Ettinger, DS | 1 |
Blamey, RW; Griffiths, K; Pearson, D; Turkes, A; Twining, P; Williams, MR | 1 |
Sedlacek, SM | 1 |
Black, WR; Capizzi, RL; Christian, R; Cooper, MR; Cruz, JM; Jackson, DV; Muss, HB; Paschold, EH; Powell, BL; Wells, HB | 1 |
Badger, G; Belinson, JL; McClure, M | 1 |
Anderson, K; Bonomi, P; Economou, S; Gale, M; Johnson, P; Von Roenn, J; Wolter, J | 1 |
Anderson, KM; Bonomi, PD; Economou, SG; Gale, M; Von Roenn, JH; Wolter, JM | 1 |
Alexieva-Figusch, J; Schrijver, J; van Breederode, N; van Gilse, HA | 1 |
Allegra, JC | 1 |
Lamberts, SW; van Koetsveld, P; Verleun, T | 1 |
Hodder, RV; Hughes, E | 1 |
Albert, J; Berry, CC; Fay, W; Geller, J; Liu, J; Weis, P | 1 |
Boublil, JL; Cavaglione, G; Kather, R; Namer, M | 1 |
Anderson, KM; Bonomi, PD; Economou, SG; Johnson, PA; Wolter, JM | 1 |
Black, WR; Capizzi, RL; Christian, R; Cooper, MR; Cruz, JM; Jackson, DV; Muss, HB; Paschold, EH; Richards, F; Stuart, JJ | 1 |
Allegra, JC; Bertino, J; Bonomi, P; Byrne, P; Carpenter, J; Catalano, R; Creech, R; Dana, B; Durivage, H; Einhorn, L | 1 |
Blankenstein, MA; de Jong, FH; Klijn, JG; Lamberts, SW | 1 |
Benghiat, A; Cassidy, SA; Davidson, HE; Mancero, FS; Pickard, JG; Tyrrell, CJ | 1 |
Morgan, LR | 1 |
Alexieva-Figusch, J; Blonk-vd Wijst, J; Klijn, JG; van Gilse, HA; Van Putten, WL | 1 |
Blumenschein, GR; Buzdar, AU; Ross, MB | 1 |
Hauri, D; Schoenenberger, A | 1 |
Blumenschein, GR | 1 |
Alexieva-Figusch, J; Blankenstein, MA; de Jong, FH; Lamberts, SW | 1 |
Klijn, JG | 1 |
Ahmann, DL; Creagan, ET; Edmonson, JH; Green, SJ; Hahn, RG; Ingle, JN; Rubin, J | 1 |
Major, FJ; Moore, GE; Myers, AM | 1 |
Mizushima, Y; Murakami, T | 1 |
Burger, CW; Greggi, S; Kenemans, P; van der Vange, N; Vermorken, JB | 1 |
Archer, SG; Barnes, D; Blamey, RW; Eliopoulos, A; Ellis, IO; Nicholson, RI; Robertson, JF; Spandidos, D | 1 |
Ahlgren, JD; Alt, D; Ellison, NM; Gottlieb, RJ; Laluna, F; Lokich, JJ; Sinclair, PR; Ueno, W; Wampler, GL; Yeung, KY | 1 |
Chinchilli, VM; Demers, L; Grossberg, H; Harvey, H; Konrad, K; Leitzel, K; Lipton, A; Teramoto, Y; Volas, G | 1 |
Harrison-Woolrych, M; Robinson, R | 1 |
Beerman, H; Bontenbal, M; Logmans, A; Mous, HV; van Lent, M | 1 |
Blamey, RW; Cannon, P; Ellis, IO; Gee, JM; Manning, DL; McClelland, RA; Nicholson, RI; Robertson, JF | 1 |
Altaras, M; Beyth, Y; Cohen, I; Cordoba, M; Shulman, A; Tepper, R | 1 |
Crawford, DJ; George, WD; Leake, RE; Paul, J; Smith, DC; Stewart, M | 1 |
Espie, M | 1 |
Chao, AS; Hsueh, S; Lai, CH; Soong, YK | 1 |
Beinfield, M; Fischer, D; Haffty, BG; McKhann, C; Wilmarth, L; Wilson, L | 1 |
Burns, I; Byrne, M; Coates, A; Gebski, V; Gill, PG; Levi, J; Snyder, R | 1 |
Borruto Caracciolo, G; Caccavale, C; Cardone, A; Di Serio, C; Tolino, A | 1 |
Azab, M; Blomqvist, C; Buzdar, A; Eiermann, W; Howell, A; Jonat, W; Jones, SE; Plourde, PV; Vogel, CL; Webster, A; Wolter, JM | 1 |
Buttafoco, P; Camellini, L; De Santis, M; Dugani, A; Fantoni, E; Ferrari, A; Grottola, A; Manenti, F; Pompei, G; Villa, E | 1 |
Helle, SI; Lønning, PE | 1 |
Kreysel, C; Porschen, R | 1 |
Confalonieri, C; Fossati, R; Ghislandi, E; Liberati, A; Penna, A; Pistotti, V; Tinazzi, A; Torri, V | 1 |
Costello, S; Glück, S; Heffernan, M; Hortobagyi, GN; Kennedy, I; Knight, RD; Leff, R; Lipton, A; Mellars, K; Reitsma, DJ; Seaman, JJ; Simeone, J; Stewart, JF; Theriault, RL | 1 |
Cao, L; Gu, ZP; Leng, Y; Yang, B | 1 |
Davis, TE; Erban, JK; Krook, JE; Pandya, KJ; Schinella, RA; Weiner, LM; Yeap, BY | 1 |
He, K; Li, J; Xu, L | 1 |
Chou, HH; Hsueh, S; Huang, HJ; Lai, CH; Soong, YK; Wang, CB; Wang, CJ | 1 |
Dow, KH | 1 |
Bertani, H; Buttafoco, P; Colantoni, A; De Maria, N; Ferretti, I; Grottola, A; Manenti, F; Villa, E | 1 |
Caruggi, M; Colombo, G; Marchetti, M | 1 |
Bell, JG; Hardy, RD; Nicely, CJ; Reid, GC | 1 |
Benedict, A; Brown, RE | 1 |
DeMichele, A; Gogineni, K | 1 |
13 review(s) available for megestrol and tamoxifen
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Overview of hormonal therapy in advanced breast cancer.
Topics: Breast Neoplasms; Female; Humans; Male; Megestrol; Megestrol Acetate; Meta-Analysis as Topic; Tamoxifen | 1990 |
Megestrol acetate: clinical experience.
Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Anorexia; Breast Neoplasms; Cachexia; Carcinoma, Renal Cell; Contraceptive Agents, Male; Contraceptives, Oral; Endometrial Hyperplasia; Female; Humans; Kidney Neoplasms; Male; Megestrol; Megestrol Acetate; Melanoma; Middle Aged; Ovarian Neoplasms; Prostatic Hyperplasia; Prostatic Neoplasms; Rabbits; Tamoxifen; Uterine Neoplasms | 1989 |
An overview of megestrol acetate for the treatment of advanced breast cancer.
Topics: Breast Neoplasms; Combined Modality Therapy; Female; Humans; Megestrol; Megestrol Acetate; Menopause; National Institutes of Health (U.S.); Tamoxifen; United States | 1988 |
[Conservative treatment of benign prostatic hyperplasia (author's transl)].
Topics: Adrenergic alpha-Antagonists; Bromocriptine; Cyproterone; Gestonorone Caproate; Humans; Male; Medrogestone; Megestrol; Plant Extracts; Polyenes; Prostatic Hyperplasia; Spironolactone; Tamoxifen | 1982 |
[Drug induced obesity].
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Antineoplastic Agents, Hormonal; Female; Gonadal Steroid Hormones; Humans; Hypoglycemic Agents; Male; Megestrol; Megestrol Acetate; Obesity; Psychotropic Drugs; Tamoxifen | 1995 |
Results of curettage for postmenopausal vaginal bleeding in women treated with tamoxifen and megestrol acetate for progressive metastatic breast carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Dilatation and Curettage; Female; Humans; Megestrol; Middle Aged; Postmenopause; Retrospective Studies; Tamoxifen; Treatment Outcome; Uterine Hemorrhage | 1994 |
Insulin-like growth factors in breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Endopeptidases; Estrogen Antagonists; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Megestrol; Neoplasms, Hormone-Dependent; Receptors, Somatomedin; Somatomedins; Tamoxifen; Tumor Cells, Cultured | 1996 |
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Megestrol; Prednisone; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen | 1998 |
Existing and emerging endocrine therapies for breast cancer.
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Down-Regulation; Estrogen Receptor Modulators; Female; Humans; Megestrol; Middle Aged; Postmenopause; Randomized Controlled Trials as Topic; Survival Rate; Tamoxifen | 2002 |
Hormonal treatment of a recurrent granulosa cell tumor of the ovary: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Granulosa Cell Tumor; Humans; Megestrol; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Tamoxifen | 2005 |
Review of cost-effectiveness analyses in hormonal therapies in advanced breast cancer.
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cost-Benefit Analysis; Decision Making; Female; Health Care Rationing; Health Expenditures; Humans; Megestrol; Models, Economic; Randomized Controlled Trials as Topic; Receptors, Estrogen; Tamoxifen | 2005 |
Current approaches to the management of Her2-negative metastatic breast cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Deoxycytidine; Doxorubicin; Estradiol; Female; Fulvestrant; Gemcitabine; Humans; Megestrol; Ovary; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; TOR Serine-Threonine Kinases | 2012 |
22 trial(s) available for megestrol and tamoxifen
Article | Year |
---|---|
A randomised trial of second-line hormone vs single agent chemotherapy in tamoxifen resistant advanced breast cancer.
Topics: Breast Neoplasms; Drug Resistance; Female; Humans; Megestrol; Megestrol Acetate; Mitoxantrone; Neoplasm Staging; Probability; Prospective Studies; Receptors, Estrogen; Tamoxifen; Time Factors; Treatment Outcome | 1992 |
Comparison of antiestrogen and progestogen therapy for initial treatment and consequences of their combination for second-line treatment of recurrent breast cancer.
Topics: Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Megestrol; Megestrol Acetate; Tamoxifen | 1990 |
Megestrol acetate versus aminoglutethimide for metastatic breast cancer.
Topics: Aged; Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Female; Follow-Up Studies; Humans; Megestrol; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1989 |
Megestrol acetate v tamoxifen in advanced breast cancer: correlation of hormone receptors and response.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Random Allocation; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1986 |
Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation; Remission Induction; Tamoxifen | 1988 |
Randomized trial of megestrol acetate vs. megestrol acetate/tamoxifen for the management of progressive or recurrent epithelial ovarian carcinoma.
Topics: Adult; Carcinoma; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Random Allocation; Tamoxifen | 1987 |
Megestrol acetate: a new role in the treatment of metastatic breast cancer.
Topics: Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1987 |
Megestrol acetate v tamoxifen in advanced breast cancer: a phase III trial of the Piedmont Oncology Association (POA).
Topics: Aged; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Tamoxifen | 1985 |
Metastatic breast cancer: preliminary results with oral hormonal therapy.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation; Tamoxifen | 1985 |
LHRH-agonist treatment in clinical and experimental human breast cancer.
Topics: Administration, Intranasal; Breast Neoplasms; Buserelin; Cell Line; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Megestrol; Megestrol Acetate; Menopause; Menstrual Cycle; Progesterone; Prolactin; Receptors, Estradiol; Tamoxifen | 1985 |
Randomized clinical trial of megestrol acetate versus tamoxifen in paramenopausal or castrated women with advanced breast cancer.
Topics: Adult; Breast Neoplasms; Castration; Clinical Trials as Topic; Female; Humans; Megestrol; Menopause; Middle Aged; Prognosis; Random Allocation; Tamoxifen | 1982 |
Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase II trials of the Mid-Atlantic Oncology Program.
Topics: Adenocarcinoma; Aminoglutethimide; Carcinoma; Drug Resistance; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Megestrol; Megestrol Acetate; Ovarian Neoplasms; Palliative Care; Tamoxifen | 1993 |
Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antigens; Breast Neoplasms; Chi-Square Distribution; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Fadrozole; Female; Gene Amplification; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Regression Analysis; Survival Analysis; Tamoxifen; Treatment Outcome | 1995 |
Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy.
Topics: Biomarkers, Tumor; Breast Neoplasms; ErbB Receptors; Female; Goserelin; Humans; Ki-67 Antigen; Megestrol; Megestrol Acetate; Menopause; Neoplasm Proteins; Nuclear Proteins; Postmenopause; Premenopause; Prognosis; Proto-Oncogene Proteins; Receptor, ErbB-2; Receptors, Estrogen; Survival Analysis; Tamoxifen | 1994 |
Cyclic sequential endocrine therapy for advanced breast cancer using a combination of tamoxifen and megestrol acetate.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Survival Rate; Tamoxifen; Treatment Outcome | 1994 |
Adjuvant systemic chemotherapy and hormonal therapy. Effect on local recurrence in the conservatively treated breast cancer patient.
Topics: Adult; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Mastectomy, Segmental; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Regression Analysis; Retrospective Studies; Tamoxifen | 1994 |
Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen; Survival Rate; Tamoxifen | 1993 |
Tamoxifen, megestrol acetate, and beta interferon in endometrial cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Endometrial Neoplasms; Female; Humans; Interferon-beta; Megestrol; Megestrol Acetate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1995 |
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Double-Blind Method; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Nitriles; Postmenopause; Prognosis; Survival Rate; Tamoxifen; Triazoles | 1996 |
Type of estrogen receptor determines response to antiestrogen therapy.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Carcinoma, Hepatocellular; Cell Division; Estrogen Antagonists; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Megestrol; Middle Aged; Pilot Projects; Receptors, Estrogen; Tamoxifen | 1996 |
Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Diseases; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Double-Blind Method; Female; Humans; Hypercalcemia; Megestrol; Middle Aged; Neoplasm Metastasis; Pamidronate; Tamoxifen | 1999 |
Megestrol and tamoxifen in patients with advanced endometrial cancer: an Eastern Cooperative Oncology Group Study (E4882).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Endometrial Neoplasms; Female; Humans; Megestrol; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Proportional Hazards Models; Survival Rate; Tamoxifen | 2001 |
44 other study(ies) available for megestrol and tamoxifen
Article | Year |
---|---|
Endometrial decidual changes in a postmenopausal woman treated with tamoxifen and megestrol acetate.
Topics: Adult; Breast Neoplasms; Endometrial Neoplasms; Endometrium; Female; Humans; Megestrol; Menopause, Premature; Polyps; Tamoxifen | 1992 |
Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer.
Topics: Aged; Aging; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Immunoenzyme Techniques; Immunohistochemistry; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Predictive Value of Tests; Prognosis; Receptors, Estrogen; Sensitivity and Specificity; Tamoxifen | 1992 |
Longterm remission of multiple brain metastases with tamoxifen.
Topics: Activities of Daily Living; Aged; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Estrogens; Female; Humans; Mastectomy, Radical; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Palliative Care; Psychomotor Disorders; Tamoxifen | 1991 |
Overprolonged adjuvant tamoxifen therapy in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Humans; Megestrol; Survival Rate; Tamoxifen | 1991 |
A pilot study of stanozolol for advanced breast carcinoma.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Carcinoma; Female; Humans; Lymphatic Metastasis; Megestrol; Megestrol Acetate; Middle Aged; Pilot Projects; Remission Induction; Stanozolol; Tamoxifen | 1991 |
The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cytotoxicity, Immunologic; Humans; Immunity, Innate; Killer Cells, Natural; Leukocyte Count; Male; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Neoplasm Staging; Tamoxifen | 1991 |
An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data.
Topics: Biomarkers, Tumor; Blood Sedimentation; Bone Neoplasms; Breast Neoplasms; Buserelin; C-Reactive Protein; Carcinoembryonic Antigen; Female; Ferritins; Goserelin; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Orosomucoid; Ovariectomy; Tamoxifen | 1990 |
Serum ferritin as a marker of therapeutic response in stage III and IV breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Buserelin; Female; Ferritins; Follow-Up Studies; Goserelin; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Staging; Ovariectomy; Remission Induction; Retrospective Studies; Tamoxifen | 1990 |
Life-threatening hypercalcemia and tamoxifen.
Topics: Aged; Calcitonin; Female; Humans; Hydrocortisone; Hypercalcemia; Megestrol; Megestrol Acetate; Prednisone; Sodium Chloride; Tamoxifen | 1990 |
Prognostic significance of estrogen and progesterone receptors in epithelial ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Tamoxifen | 1990 |
Effect of antiandrogen and/or antiestrogen blockade on human prostate epithelial and stromal cell protein synthesis.
Topics: Dihydrotestosterone; Epithelium; Humans; Ketoconazole; Kinetics; Male; Megestrol; Megestrol Acetate; Prostate; Prostatic Hyperplasia; Protein Biosynthesis; Tamoxifen | 1986 |
Ocular toxicity of tamoxifen.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorescein Angiography; Head and Neck Neoplasms; Humans; Megestrol; Middle Aged; Retinal Diseases; Tamoxifen; Visual Acuity | 1989 |
Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapy.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1989 |
[Which hormone therapy should be used in advanced breast carcinoma in males?].
Topics: Adenocarcinoma; Aged; Aminoglutethimide; Axilla; Breast Neoplasms; Dexamethasone; Drug Evaluation; Humans; Lymphatic Metastasis; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Tamoxifen; Testolactone; Testosterone Congeners | 1988 |
Progestational agents in advanced breast cancer: an overview.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Menopause; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prognosis; Receptors, Cell Surface; Tamoxifen | 1986 |
The use of serum carcinoembryonic antigen to assess therapeutic response in locally advanced and metastatic breast cancer: a prospective study with external review.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Female; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Middle Aged; Prospective Studies; Tamoxifen; Viscera | 1988 |
Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Regression Analysis; Retrospective Studies; Tamoxifen | 1988 |
Sequential hormone therapy for advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Soft Tissue Neoplasms; Tamoxifen | 1988 |
Investigations on the nutritional status of advanced breast cancer patients. The influence of long-term treatment with megestrol acetate or tamoxifen.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Catecholamines; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Nutritional Status; Pyridoxine; Steroids; Tamoxifen; Trace Elements | 1987 |
Prolactin release-inhibitory effects of progesterone, megestrol acetate, and mifepristone (RU 38486) by cultured rat pituitary tumor cells.
Topics: Animals; Cells, Cultured; Dexamethasone; Estradiol; Estrenes; Megestrol; Megestrol Acetate; Mifepristone; Pituitary Neoplasms; Progesterone; Prolactin; Rats; Rats, Inbred BUF; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone; Tamoxifen | 1987 |
Pulmonary lymphangiomyomatosis complicating pregnancy. A case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chylothorax; Female; Humans; Lung Neoplasms; Lymphangiomyoma; Lymphoproliferative Disorders; Megestrol; Megestrol Acetate; Pregnancy; Pregnancy Complications, Neoplastic; Tamoxifen | 1987 |
Relationship between human prostatic epithelial cell protein synthesis and tissue dihydrotestosterone level.
Topics: Aged; Dihydrotestosterone; Epithelium; Humans; Ketoconazole; Male; Megestrol; Megestrol Acetate; Prostate; Protein Biosynthesis; Tamoxifen | 1987 |
[Cancer of the prostate: new hormone therapies].
Topics: Androgen Antagonists; Cyproterone; Flutamide; Humans; Ketoconazole; Male; Medroxyprogesterone; Megestrol; Neoplasms, Hormone-Dependent; Progestins; Prostatic Neoplasms; Tamoxifen | 1986 |
Megestrol acetate: first-line therapy for advanced breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Male; Megestrol; Megestrol Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Retrospective Studies; Tamoxifen | 1986 |
Megestrol acetate in the treatment of advanced post-menopausal breast cancer.
Topics: Aged; Body Weight; Breast Neoplasms; Carcinoma; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Tamoxifen; Time Factors | 1986 |
Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1985 |
Sequential treatment of metastatic breast cancer with tamoxifen after megestrol acetate therapy and vice versa (a retrospective study).
Topics: Administration, Oral; Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Prognosis; Tamoxifen | 1985 |
Treatment of advanced breast cancer with megestrol acetate after therapy with tamoxifen.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Palliative Care; Prognosis; Tamoxifen | 1982 |
The role of progestins in the treatment of breast cancer.
Topics: Breast Neoplasms; Cell Line; Cytoplasm; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1983 |
Endocrine effects of the combination of megestrol acetate and tamoxifen in the treatment of metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Prolactin; Sex Hormone-Binding Globulin; Tamoxifen; Thyrotropin-Releasing Hormone | 1984 |
Long-term LHRH-agonist treatment in metastatic breast cancer as a single treatment and in combination with other additive endocrine treatments.
Topics: Breast Neoplasms; Buserelin; Drug Therapy, Combination; Female; Humans; Megestrol; Megestrol Acetate; Tamoxifen | 1984 |
Advanced ovarian carcinoma: response to antiestrogen therapy.
Topics: Adult; Cystadenocarcinoma; Estrogen Antagonists; Female; Humans; Megestrol; Middle Aged; Nafoxidine; Neoplasm Metastasis; Ovarian Neoplasms; Tamoxifen | 1981 |
Experience with hormonal therapy in advanced epithelial ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Carcinoma; Estrogen Antagonists; Female; Flutamide; Gonadotropin-Releasing Hormone; Humans; Luteolytic Agents; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Ovarian Neoplasms; Progesterone Congeners; Remission Induction; Survival Rate; Tamoxifen; Triptorelin Pamoate | 1995 |
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; ErbB Receptors; Estrogen Antagonists; Female; Gene Expression Regulation, Neoplastic; Goserelin; Humans; Ki-67 Antigen; Life Tables; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Nuclear Proteins; Proportional Hazards Models; Proto-Oncogene Proteins p21(ras); Receptor, ErbB-2; Receptors, Estrogen; Tamoxifen; Treatment Outcome; Tumor Suppressor Protein p53 | 1995 |
Fibroid growth in response to high-dose progestogen.
Topics: Breast Neoplasms; Carcinoma; Dose-Response Relationship, Drug; Female; Humans; Leiomyoma; Megestrol; Megestrol Acetate; Middle Aged; Progestins; Tamoxifen; Ultrasonography; Uterine Neoplasms | 1995 |
Estrogen and progesterone receptor expression of decidual endometrium in a postmenopausal woman treated with tamoxifen and megestrol acetate.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Endometrium; Estrogens; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1994 |
Megestrol acetate in advanced breast carcinoma.
Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Cross-Over Studies; Female; Humans; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Postmenopause; Prospective Studies; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome | 1994 |
Successful pregnancy after tamoxifen and megestrol acetate therapy for endometrial carcinoma.
Topics: Adenocarcinoma; Adult; Endometrial Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Pregnancy; Tamoxifen | 1994 |
[Does anti-estrogen therapy after estrogen receptor analysis have value in palliative therapy of hepatocellular carcinoma?].
Topics: Antineoplastic Agents, Hormonal; Carcinoma, Hepatocellular; Estrogen Antagonists; Follow-Up Studies; Humans; Liver Neoplasms; Megestrol; Palliative Care; Receptors, Estrogen; Tamoxifen; Treatment Outcome | 1998 |
Effects of anordrin, droloxifene, nomegestrol, and mifepristone on cultured rat luteal cell apoptosis.
Topics: Animals; Apoptosis; Cell Survival; Cells, Cultured; Contraceptives, Oral, Synthetic; Corpus Luteum; Estrogen Antagonists; Female; Luteolytic Agents; Megestrol; Mifepristone; Norandrostanes; Progesterone Congeners; Rats; Rats, Sprague-Dawley; Tamoxifen | 1999 |
[Modulation of multiple drug resistance by nomegestrol acetate and droloxifene in K562/A02].
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; DNA Topoisomerases, Type II; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Estrogen Antagonists; Gene Expression; Genes, MDR; Glutathione Transferase; Humans; K562 Cells; Megestrol; Norpregnadienes; RNA, Messenger; Tamoxifen | 1999 |
Fertility-preserving treatment in young patients with endometrial adenocarcinoma.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Disease Progression; Endometrial Neoplasms; Female; Fertility; Gonadotropin-Releasing Hormone; Humans; Megestrol; Megestrol Acetate; Pelvis; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Treatment Outcome; Ultrasonography | 2002 |
Variant estrogen receptors and their role in liver disease.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Division; Estrogen Receptor Modulators; Exons; Female; Genetic Variation; Humans; Male; Megestrol; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Sequence Deletion; Survival Analysis; Tamoxifen | 2002 |
Cost utility and budget impact of third-generation aromatase inhibitors for advanced breast cancer: a literature-based model analysis of costs in the Italian National Health Service.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Budgets; Cost-Benefit Analysis; Decision Support Techniques; Drug Costs; Female; Humans; Italy; Letrozole; Markov Chains; Megestrol; Models, Economic; National Health Programs; Nitriles; Postmenopause; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles | 2004 |